The Isthmus Foundation commercialization of Rapidly Endothelialized Vascular Bypass Grafts and Liquid-Nitrogen Free Cryopreservation Storage System

Our goal is focused on developing the commercial pathway for two translational stem cell related projects in Minnesota, one creating Rapidly Endothelialized Vascular Bypass Grafts, a non-clotting blood vessel product for bypass surgeries and a second project, where TIF is the Managing Partner, building a novel low power, liquid nitrogen-free, cryogenic storage solution for the ultra-low temperature biologics in supply chain.